Key result
Higher epicardial adipose tissue volume was significantly associated with non-alcoholic fatty liver disease (OR 1.407; 95% CI 1.117-1.773) after adjusting for main cardiovascular risk factors.
Why the study?
Is epicardial adipose tissue volume associated with non-alcoholic fatty liver disease and cardiovascular risk factors in the general population?
Cross-Sectional (n=2,238)
No
Is epicardial adipose tissue volume associated with non-alcoholic fatty liver disease and cardiovascular risk factors in the general population?
Odds Ratio: 1.407 (95% CI 1.117–1.773)
Epicardial adipose tissue volume is significantly associated with non-alcoholic fatty liver disease and other cardiovascular risk factors in the general population.
Hypothesis-generating for EAT as NAFLD correlate; leaves open causal CV links and requires prospective validation before practice change.
No takes yet. Share an insight, caveat, or question.
Meng et al. (2018) conducted a cross-sectional in Non-alcoholic fatty liver disease and cardiovascular risk factors (n=2,238). Higher epicardial adipose tissue volume was evaluated on Non-alcoholic fatty liver disease (NAFLD) (OR 1.407, 95% CI 1.117-1.773). Higher epicardial adipose tissue volume was significantly associated with non-alcoholic fatty liver disease (OR 1.407; 95% CI 1.117-1.773) after adjusting for main cardiovascular risk factors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: